Lista de obras - Julian Romero - Dominio Público Uruguay

A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis.

artículo científico publicado en 2005

A restricted population of CB1 cannabinoid receptors with neuroprotective activity

artículo científico publicado en 2014

Activational role of cannabinoids on movement

artículo científico publicado en 2000

Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.

artículo científico publicado en 1998

Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity.

artículo científico publicado en 2002

Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study.

artículo científico publicado en 2011

Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa

artículo científico publicado en 2008

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

artículo científico publicado en 2006

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains

artículo científico publicado en 2003

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease

artículo científico publicado en 2018

Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system

artículo científico publicado en 2018

Cannabinoid receptor binding did not vary in several hypothalamic nuclei after hypothalamic deafferentation ⬇️

artículo científico publicado el 1 de enero de 1998

Changes in CB1 and CB2 receptors in the post‐mortem cerebellum of humans affected by spinocerebellar ataxias ⬇️

artículo científico publicado el 1 de marzo de 2014

Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats ⬇️

artículo científico publicado el 30 de septiembre de 1998

Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol

artículo científico publicado en 1995

Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain ⬇️

artículo científico publicado el 30 de marzo de 1998

Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis.

artículo científico publicado en 2004

Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance

scientific article published on 29 February 2008

Endocannabinoid regulation of amyloid-induced neuroinflammation.

artículo científico publicado en 2015

Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias

artículo científico publicado en 2014

Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others

artículo científico

Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.

artículo científico publicado en 2015

Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9-Tetrahydrocannabinol-Tolerant Rats

artículo científico publicado en 2000

Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand

artículo científico publicado en 1996

Involvement of GABA(B) receptors in the motor inhibition produced by agonists of brain cannabinoid receptors

artículo científico publicado en 1996

Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development.

artículo científico publicado en 1998

Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.

artículo científico publicado en 1998

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.

artículo científico publicado en 2010

Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors.

artículo científico publicado en 2013

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.

artículo científico publicado en 2009

Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets.

artículo científico publicado en 2008

Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats.

artículo científico publicado en 1999

Pharmacological and biochemical interactions between opioids and cannabinoids.

artículo científico publicado en 1999

Prospects for cannabinoid therapies in basal ganglia disorders ⬇️

artículo científico publicado el 1 de agosto de 2011

Revisiting cannabinoid receptor 2 expression and function in murine retina

scientific article published on 16 August 2018

Role of the endocannabinoid system in Alzheimer's disease: new perspectives.

artículo científico publicado en 2004

Role of the superior colliculus in the motor effects of cannabinoids and dopamine

artículo científico publicado en 2000

The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis.

artículo científico publicado en 2008

The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages

artículo científico publicado en 2009

The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.

artículo científico publicado en 1998

The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats.

artículo científico publicado en 2007

The endocannabinoid system in neuropathological states.

artículo científico publicado en 2009

The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons

artículo científico publicado en 1995

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

artículo científico publicado en 2002

The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors.

artículo científico publicado en 2009

The seek of neuroprotection: introducing cannabinoids.

artículo científico publicado en 2007

Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: Evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics ⬇️

artículo científico publicado el 15 de junio de 1997

Lista de obras de Julian Romero

A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis.

A restricted population of CB1 cannabinoid receptors with neuroprotective activity

Activational role of cannabinoids on movement

Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.

Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity.

Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study.

Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease

Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system

Cannabinoid receptor binding did not vary in several hypothalamic nuclei after hypothalamic deafferentation ⬇️

Changes in CB1 and CB2 receptors in the post‐mortem cerebellum of humans affected by spinocerebellar ataxias ⬇️

Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats ⬇️

Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol

Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain ⬇️

Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis.

Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance

Endocannabinoid regulation of amyloid-induced neuroinflammation.

Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias

Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others

Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.

Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9-Tetrahydrocannabinol-Tolerant Rats

Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand

Involvement of GABA(B) receptors in the motor inhibition produced by agonists of brain cannabinoid receptors

Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development.

Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.

Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors.

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.

Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets.

Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats.

Pharmacological and biochemical interactions between opioids and cannabinoids.

Prospects for cannabinoid therapies in basal ganglia disorders ⬇️

Revisiting cannabinoid receptor 2 expression and function in murine retina

Role of the endocannabinoid system in Alzheimer's disease: new perspectives.

Role of the superior colliculus in the motor effects of cannabinoids and dopamine

The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis.

The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages

The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.

The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats.

The endocannabinoid system in neuropathological states.

The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors.

The seek of neuroprotection: introducing cannabinoids.

Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: Evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics ⬇️